Results 101 to 110 of about 66,400 (293)
Confessions of a Poverty Researcher: My Journey Through the Foothills of Scholarship
ABSTRACT This paper describes the key events, experiences and ideas that influenced the author's career as a poverty researcher. He describes how his early disillusion with economics was replaced by a spark of interest in social issues and how his migration from the UK to Australia in the mid‐1970s provided the impetus to begin what became a lifetime ...
Peter Saunders
wiley +1 more source
Estimation of Social Cost of Monopoly in Insurance Industry:A Case Study of Iran [PDF]
"Competition" and "monopoly" are two important issues in market structure analysis. Theoretically, monopoly structure in an industry results in distorted resource allocation, bringing about economic rents.
Mohammadnabi Shahekitash +1 more
doaj
Corporate social responsibility in the international insurance industry [PDF]
Bert Scholtens
openalex +1 more source
ABSTRACT Disability support has shifted towards models of personalised care, which critics argue may contribute to increased inequalities. There is limited systematic evidence investigating inequalities in support among children with disabilities. To investigate inequalities in support, a survey of parents of children with disabilities aged 2–17 was ...
Martin O'Flaherty +2 more
wiley +1 more source
The Cost of the National Disability Insurance Scheme: Australia's Print‐Media Discourse
ABSTRACT This paper examines the way that Australian newspapers have framed the cost of the National Disability Insurance Scheme (NDIS). Introduced in 2013, the NDIS represented a major change in Australia's disability support policy, moving for the first time to a nationwide universal insurance model.
Meera Chinnappa +2 more
wiley +1 more source
The Impact of COVID-19 on the Insurance Industry. [PDF]
Babuna P +5 more
europepmc +1 more source
ABSTRACT For adults with intellectual disability and their families, future planning and moving out of the family home in Australia will increasingly occur within the context of the National Disability Insurance Scheme (NDIS). As a market‐based, individualised funding system its impact on this transition remains largely unknown. This paper reports on a
I. Belperio +5 more
wiley +1 more source
Objective To assess real‐world effectiveness of switching disease‐modifying therapy (DMT) in pediatric multiple sclerosis (MS) and clinically isolated syndrome (CIS) initially treated with platform injectables on disease activity. Methods Of 2615 pediatric‐onset demyelinating disease patients at 12 clinics in the United States (US) Network of Pediatric
Aaron W. Abrams +27 more
wiley +1 more source
Objective: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint pain, swelling, and stiffness. While smoking is a well‐established risk factor for RA, the role of occupational inhalants in RA development is less well recognized.
Qianwen Liu +7 more
wiley +1 more source

